Mycobacterium tuberculosis Beijing Strain, Bamako, Mali
Bassirou Diarra1, Sophia Siddiqui1 , Dramane Sogoba, Brehima Traore, Mamoudou Maiga, Janice Washington, Anatole Tounkara, and Michael A. Polis
Author affiliations: Project SEREFO-NIAID/University of Bamako Research Collaboration on HIV/TB, Bamako, Mali (B. Diarra, D. Sogoba, B. Traore, M. Maiga, A. Tounkara); National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA (S. Siddiqui, M.A. Polis); US Food and Drug Administration, Silver Spring, Maryland, USA (J. Washington); 1These authors contributed equally to this article.
Appendix Figure. A) Identification of isolates of the Mycobacterium tuberculosis Beijing clade (6) by using spoligotyping. The spoligotype pattern of the M. tuberculosis Beijing clade is characterized by the absence of hybridization of spacers 1–34 as shown, in combination with hybridization of spacers 35–43. Negative control (Neg.) shows absence of all spacers. For comparison, H37Rv (a laboratory strain) and M. bovis BCG show different patterns of spacers. Also shown are other clades not identified. B) Restriction fragment length polymorphism (7) patterns of strains from the 2 patients. Patterns confirm that both strains belong to the Beijing clade. However, patterns indicate different strains and confirm lack of direct transmission between the patients. The 2 additional clades shown (not from these patients) illustrate differences between the Beijing and other clades.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.